XOLAIR
As listed in the register: XOLAIR 300 mg, solution injectable en stylo prérempli
300 mg · solution injectable
- Prescription only
- Active substance
- Omalizumab
- Made by
- NOVARTIS EUROPHARM (IRLANDE)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
European UnionNo exact match for this strength and form
CanadaNo exact match for this strength and form
Details
| Made by | NOVARTIS EUROPHARM (IRLANDE) |
|---|---|
| Active substance | Omalizumab |
| Strength | 300 mg |
| Form | solution injectable |
| Route | sous-cutanée |
| Dispensing (as stated by the register) | prescription réservée aux spécialistes et services PEDIATRIE · prescription réservée aux spécialistes et services MEDECINE INTERNE · prescription réservée aux spécialistes et services PNEUMOLOGIE · prescription réservée aux spécialistes et services DERMATOLOGIE · liste I · prescription réservée aux spécialistes et services OTO-RHINO-LARYNGOLOGIE · prescription réservée aux spécialistes et services ALLERGOLOGIE |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/05/319 |
| Name in the register | XOLAIR 300 mg, solution injectable en stylo prérempli |
| Packs | 1 seringue préremplie en verre de 2 mL dans stylo pré-rempli |
| CIS | 65134723 |
| CIP13 | 3400930281147 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Other strengths and forms
6 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- solution injectable6 products
75 mg2
75 mg · 2 companies
150 mg2
150 mg · 2 companies
300 mg2
300 mg · 2 companies
- NOVARTIS EUROPHARM (IRLANDE) · this page
- NOVARTIS EUROPHARM (IRLANDE)
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.